Menu
  • Accueil
  • Ressources
  • Webinaires
  • Nouvelles
  • Stats
  • Forums
  • Équipe
  • Contact
  • Mon compte
  • EN
  • Accueil
  • Ressources
  • Webinaires
  • Nouvelles
  • Stats
  • Forums
  • Équipe
  • Contact
  • Mon compte
  • EN
Accueil/Base de connaissances/Ophtalmologie

Chloroquine, Hydroxychloroquine and Retinal Toxicity: Are Ophthalmologists Concerned?

13 views 0 06/25/2020 Belinda Jiao

  1. The primary determinants of risk of retinopathy with use of Chloroquine (CQ) and Hydroxychloroquine (HCQ) :
    • Dose (≤5.0 mg/kg/day)
    • Weight (real patient weight)
    • Duration of treatment1
  2. There is a risk of retinal toxicity after long-term use. At the AAO*’s recommended dose of ≤5.0 mg/kg/day(real weight), patients have less than 1% risk in the first 5 years of therapy and less than 2% up to 10 years. The risk increases to 20% after 20 years. Risks are much greater with higher doses.2
  3. The proposed doses to treat COVID-19 are actually 4-5 greater but used very briefly. Based on Marmor et al.’s recent article, extreme doses of CQ/HCQ do accelerate retinal damage, but more probable after many months rather than days.1
  4. If these drugs are suggest to be used for >1 year, annual screening should be considered.1
  5. Retinopathy is not of serious concern regarding CQ/HCQ usage during the pandemic, but as new treatment protocols emerge, risk of retinopathy should still be carefully studied.1

 

This data mainly comes from the analysis of the article by “COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?” by Marmor et al, that analyzes the risk of retinal toxicity in light of its usage during the pandemic.

 

Sources:

  1. Marmor, M. F. (2020). COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern? American Journal of Ophthalmology. doi: 10.1016/j.ajo.2020.03.029
  2. Marmor, M. F., Kellner, U., Lai, T. Y., Melles, R. B., & Mieler, W. F. (2016). Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).Ophthalmology, 123(6), 1386–1394. doi: 10.1016/j.ophtha.2016.01.058

*AAO = American Academy of Ophthalmology

Étiquettes:riskchloroquinehydroxychloroquineRetinopathyRetinal Toxicity

Cela a-t-il été utile ?

Oui  Non
Articles apparentés
  • Ocular Manifestations of Patients With COVID-19
  • Adapting treatment strategy for neovascular age-related macular degeneration in the current pandemic context
  • Infection Control Measures in Ophthalmology
Ophtalmologie
  • Chloroquine, Hydroxychloroquine and Retinal Toxicity: Are Ophthalmologists Concerned?
  • Ocular Manifestations of Patients With COVID-19
  • Adapting treatment strategy for neovascular age-related macular degeneration in the current pandemic context
  • Infection Control Measures in Ophthalmology
Articles populaires
  • Acute Acro-Ischemic Lesions in Children
  • Insights About Reinfection and Immunization
  • What Is the Efficacy of Masks in Preventing Transmission?
  • Rationale of Old Antimalarial Drugs Against New Pandemic
  • PPE requirement for Aerosol Generating Medical Procedures
Spécialités
  • Protection des travailleurs de la santé
  • Stades de l'infection COVID-19
    • Présomption et Prévention
    • Dépistage et Diagnostic
    • Infection Faible
    • Infection Modérée
    • Infection Sévère
    • Résultats
  • Médecine d'urgence
  • Hématologie
  • Soins intensifs
  • Santé publique
  • Respirologie
  • Gastroentérologie
  • Médecine préventive
  • Pédiatrie
  • ORL
  • Radiologie
  • Psychiatrie
  • Maladies infectieuses
  • Chirurgie
  • Oncologie
  • Neurologie
  • Cardiologie
  • Obstétrique Gynécologie
  • Pharmacologie
  • Anesthésiologie
  • Chirurgie dentaire
  • Autres spécialités de la médecine interne
  • Dermatologie
  • Gériatrie et soins palliatifs
  • Endocrinologie
  • Ophtalmologie
À propos How I Treat COVID-19

Notre site web a pour vocation d’aider les professionnels de la santé à trouver des informations précises et actualisées sur les meilleures façons de gérer et de traiter les patients touchés par l’épidémie de COVID-19.

Navigation
  • Ressources
  • Nouvelles
  • Webinaires
  • Forum
Liens utiles
  • Protocoles COVID-19
  • Santé Canada
  • WHO
  • CDC
Pratique

  • Politique de confidentialité
  • Termes et conditions
  • How I Treat Covid-19 © 2020 Développé avec ♥ par Mondien